Guideline-Directed Medical Therapy Use and Dose Optimization after TAVR in Patients with Persistent HFrEF2026-07-060 PRE AI JJason Galo OOri Waksman AAbdullah Al-Qaraghuli MMatteo Cellamare RRon Waksman FFarooq H. Sheikh TToby Rogers * DOI:10.1016/j.cardfail.2026.06.012OriginalOriginal request for helpShareSaveAbstract En